To investigate the effect of co existance of diabetes mellitus and chronic kidney disease on basic coagulation profile in comparison with diabetic patients with normal kidney function and non diabetic patients with chronic kidney disease
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Estimate risk of thrombosis or bleeding for the 3 study groups by prothrombin time
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by prothrombin concentration
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by INR
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by partial thromboplastin time
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by serum fibrinogen
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by mean platelet volume
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by platelet distribution width
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by plateletcrit
Timeframe: 1 day